Modafinil For Shift-Work Sleep Disorder-Related Excessive Sleepiness

Modafinil For Shift-Work Sleep Disorder-Related Excessive Sleepiness

Modafinil for Shift-Work Sleep Disorder-Related Excessive Sleepiness is a pharmaceutical medication that can treat excessive sleepiness. This medicine has been in use for a number of years and has been proven to be beneficial in treating numerous diseases.

Adverse Events

When it comes to excessive sleepiness caused by a shift-work sleep disorder, Modvigil 200 Buy Online can offer patients an effective treatment option. It can help to reduce sleepiness, increase alertness, and improve performance. However, the long-term effects of modafinil on the shift-work population are unknown. Therefore, physicians should periodically evaluate the medication’s usefulness.

Adverse events occurred in 7 percent of patients, with the most common being headaches. Of these adverse events, the most common psychiatric symptoms were anxiety, agitation, and depression. In addition, some participants stopped taking the medication because of headaches.

Modafinil was well tolerated. Nevertheless, patients still experienced high levels of sleepiness. Despite this, they showed significant improvement in some of the functional outcomes of their shift-work sleep disorder.


A shift-work sleep disorder (SWSD) is a disorder associated with an excessive amount of sleepiness during waking hours. This disorder can be a real health risk for the shift worker and can affect their family’s ability to enjoy the quality of life they have worked hard to achieve. Symptoms include fatigue, headaches, sleep-onset insomnia, and difficulty concentrating.

Studies have shown that people with a shift-work sleep disorder may experience more accidents and workplace injuries than those who do not work during a nonstandard time. Also, studies have shown that shift workers are less productive during their nights and days, and are more likely to miss important family events, such as weddings, funerals, or birthdays.

A shift-work sleep disorder can be treated by taking prescription wake-promoting medications such as Artvigil 150 Australia. But this medication is not meant to be a replacement for good sleep hygiene.

There are many nonpharmacologic treatments available for a shift-work sleep disorder. One of these is the use of light. Exposure to appropriate levels of light has been shown to improve alertness during a night shift.

Treatment Options

A shift-work sleep disorder (SWSD) is a condition that affects many people. It is characterized by a lack of energy during the day, and a need to sleep at night.

Modafinil is a medication used to treat shift-work sleep disorder-related excessive sleepiness. The medication is usually taken once a day. In addition, modafinil may be able to reduce adverse effects related to sleep disorders.

A 12-week trial was conducted to study the effects of modafinil on the symptoms of sleepiness and the quality of life in patients with SWSD. The study recruited 204 patients. These patients met the following criteria: They had moderately ill sleepiness during their work nights, they had reported sleepiness on their commute home, and they had a daily work schedule that included at least six hours of work.

Patients were administered 200 mg of modafinil, or a placebo, every day for two weeks. After a minimum two-week washout period, the placebo group received an alternative treatment.


Modafinil, also known as Provigil, is used to treat excessive sleepiness. It is commonly taken as a tablet by mouth. The medication starts working within 30-60 minutes and works to improve sleep and increase alertness in patients with excessive sleepiness.

This study evaluated the effects of modafinil on sleep and cognitive performance in patients with a shift-work sleep disorder. To participate in the study, patients were required to meet a number of criteria. They needed to have reported moderately ill sleepiness on work nights, reported that they had a daily commute home in the evening, and reported that their sleep efficiency was less than 87.5 percent on daytime polysomnography.

Subjects who took modafinil had a small but significant improvement in their sleep and performance. Compared with patients taking a placebo, the modafinil group had lower overall mean sleep latencies and patient-estimated sleepiness and improved sustained attention performance. However, modafinil produced few or no significant effects on other sleep measures during the night shift.